Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)
Sheila M. Galloway(United States Military Academy), Günter Speit(Universität Ulm), Elisabeth Lorge(Servier (France)), Robert H. Heflich(National Center for Toxicological Research), Takeshi Morita(National Institute of Health Sciences), Mick D. Fellows(AstraZeneca (United Kingdom)), Marilyn J. Aardema(Procter & Gamble (United States)), David Kirkland(Covance (United States)), Anthony M. Lynch(Age UK), Daniel Marzin(Université de Lille), David A. Eastmond, Maik Schuler(Pfizer (United States)), Dan D. Levy(United States Food and Drug Administration)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
January 20, 2011
Cited by 57
Related Papers
Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells
|Mutagenesis|2010|1.2k
Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals
|Environmental and Molecular Mutagenesis|1987|661
Report from the in vitro micronucleus assay working group
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2003|625
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
|Regulatory Toxicology and Pharmacology|2006|461
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2007|437